Ms. Kiwon Jang has been working as a principal researcher at the Korea Institute of Nuclear Safety (KINS) since 2005. She is a team leader in the Department of Radiation Protection and Radioactive Waste Safety Assessment.
Ms. Kiwon Jang graduated from the Hanyang University in Seoul in 2003 with a major in Nuclear Engineering. In 2005, she obtained a Master’s degree in Health Physics from the Hanyang University. During her Master's program, she conducted research on the assessment and measurement of radiation exposure in patients undergoing CT, utilizing physical phantoms.
Ms. Jang has extensive experience in the field of radiation safety and regulation. From 2005 to 2007, she actively participated in tasks related to the safety regulation of radiation sources. From 2007 to 2013, she played a pivotal role as a member of the radiation emergency response team at KINS. Currently, she is actively engaged in the field of radiation protection and environmental regulation in nuclear facilities. In her ongoing responsibilities, she meticulously ensures compliance with regulatory requirements within the facilities and significantly contributed to the enhancement of overall safety standards in radiation protection. In 2022, she assumed a leadership position in the Department of Radiation Protection and Radioactive Waste Safety Assessment, further building upon her expertise and making significant contributions to the improvement of radiation safety.
Ms. Jang has been member of Korean delegations since 2020, and the Alternate representative of the Republic of Korea for its sixty-eighth and sixty-ninth sessions. She is the Representative for the seventieth session in 2023.
Dr Jin Kyung Lee was appointed as President of the Korea Institute of Radiological and Medical Sciences (KIRAMS) in April 2023. She has been working as an attending physician at the Korea Cancer Center Hospital of KIRAMS since 2005. She was a director in the department of laboratory medicine and also in the department of life/health promotion which oversees a radiation effect clinic and a cancer screening clinic.
Dr Lee graduated in 1992 from the Ewha Womans University college of medicine in Seoul and received a medical doctor (MD) degree followed by a PhD degree from the Chungbuk University in 2002. During her residency, she focused on molecular diagnostics and cytogenetics for cancer patients. In 1998, she received the board certificate from the Korean Society of Laboratory Medicine.
Dr Lee's research interests focuses on developing biomarkers for targeted cancer therapy and its resistance. She has published many articles dealing with genetic profiling of cancer cells aiming for precision oncology. She recently is interested in cancer susceptibility genes and hereditary cancer syndromes. As advances in high-throughput sequencing technologies enabled discovery of increasing number of germline and somatic variations, her research has expanded to an interaction between germline predisposition and accumulation of somatic variations and its effect to carcinogenesis.
Dr Lee is a member of the Association for Molecular Pathology (AMP) and served as a Korean delegate for International Affairs Committee of AMP since 2019.
Dr Lee has been member of Korean delegations since 2012, and the alternate representative of Korea since its sixty-fifth session in 2018.
